Home/Filings/4/0001209191-18-062105
4//SEC Filing

Arcudi III Louis J 4

Accession 0001209191-18-062105

CIK 0001544227other

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 7:35 PM ET

Size

5.7 KB

Accession

0001209191-18-062105

Insider Transaction Report

Form 4
Period: 2018-12-07
Arcudi III Louis J
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-12-07+74,40074,400 total
    Exercise: $10.39Exp: 2028-12-06Common Stock (74,400 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on November 1, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Millendo Therapeutics, Inc.

CIK 0001544227

Entity typeother

Related Parties

1
  • filerCIK 0001419350

Filing Metadata

Form type
4
Filed
Dec 10, 7:00 PM ET
Accepted
Dec 11, 7:35 PM ET
Size
5.7 KB